{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:25:47Z","timestamp":1790436347770,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005878","name":"Terveyden Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["115372"],"award-info":[{"award-number":["115372"]}],"id":[{"id":"10.13039\/501100005878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009067","name":"K. Albin Johanssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003128","name":"Ty\u00f6suojelurahasto","doi-asserted-by":"publisher","award":["109003"],"award-info":[{"award-number":["109003"]}],"id":[{"id":"10.13039\/501100003128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5652-y","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:04:13Z","timestamp":1559037853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5769-3010","authenticated-orcid":false,"given":"Eeva","family":"Kettunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauli","family":"Savukoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisa","family":"Salmenkivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"B\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Vanhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Kuosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisko","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"Suppl 5","key":"5652_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1289\/ehp.97105s51073","volume":"105","author":"M Jaurand","year":"1997","unstructured":"Jaurand M. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect. 1997;105(Suppl 5):1073\u201384.","journal-title":"Environ Health Perspect"},{"key":"5652_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.ajpath.2012.12.028","volume":"182","author":"BT Mossman","year":"2013","unstructured":"Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R. New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. Am J Pathol. 2013;182:1065\u201377.","journal-title":"Am J Pathol"},{"key":"5652_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","volume":"34","author":"Y Sekido","year":"2013","unstructured":"Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34:1413\u20139.","journal-title":"Carcinogenesis."},{"key":"5652_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1289\/ehp.6704","volume":"112","author":"J LaDou","year":"2004","unstructured":"LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112:285\u201390.","journal-title":"Environ Health Perspect"},{"key":"5652_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5271\/sjweh.3462","volume":"41","author":"H Wolff","year":"2015","unstructured":"Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41:5\u201315.","journal-title":"Scand J Work Environ Health"},{"key":"5652_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.lungcan.2009.03.018","volume":"67","author":"P Andujar","year":"2010","unstructured":"Andujar P, Wang J, Descatha A, Galateau-Sall\u00e9 F, Abd-Alsamad I, Billon-Galland M-A, Blons H, Clin B, Danel C, Housset B, et al. p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer. 2010;67:23\u201330.","journal-title":"Lung Cancer"},{"key":"5652_CR7","volume-title":"WHO classification of tumours of the lung, pleura, thymus and heart","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: IARC; 2015.","edition":"4"},{"key":"5652_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4471-2825-0_19","volume-title":"Occupational cancers","author":"E Kettunen","year":"2014","unstructured":"Kettunen E, Knuutila S. Malignant mesothelioma, molecular markers. In: Anttila SL, Boffetta P, editors. Occupational cancers. London: Springer; 2014. p. 325\u201343."},{"key":"5652_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.lungcan.2008.02.013","volume":"62","author":"N Kobayashi","year":"2008","unstructured":"Kobayashi N, Toyooka S, Yanai H, Soh J, Fujimoto N, Yamamoto H, Ichihara S, Kimura K, Ichimura K, Sano Y, et al. Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma. Lung Cancer. 2008;62:120\u20135.","journal-title":"Lung Cancer"},{"key":"5652_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0169-5002(02)00178-2","volume":"38","author":"L Wong","year":"2002","unstructured":"Wong L, Zhou J, Anderson D, Kratzke R. Inactivation of p16INK4a expression in malignant mesothelioma by methylation. Lung Cancer. 2002;38:131\u20136.","journal-title":"Lung Cancer"},{"key":"5652_CR11","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yexmp.2012.04.001","volume":"93","author":"AA Bahnassy","year":"2012","unstructured":"Bahnassy AA, Zekri AR, Abou-Bakr AA, El-Deftar MM, El-Bastawisy A, Sakr MA, El-Sherif GM, Gaafar RM. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients. Exp Mol Pathol. 2012;93:154\u201361.","journal-title":"Exp Mol Pathol"},{"key":"5652_CR12","first-page":"5547","volume":"54","author":"JQ Cheng","year":"1994","unstructured":"Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee W-C, Altomare DA, Nobori T, Olopade OI, Buckler AJ, Testa JR. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 1994;54:5547\u201351.","journal-title":"Cancer Res"},{"key":"5652_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jcp.2010.076794","volume":"63","author":"CT Chung","year":"2010","unstructured":"Chung CT, Santos Gda C, Hwang DM, Ludkovski O, Pintilie M, Squire JA, Tsao MS. FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol. 2010;63:630\u20134.","journal-title":"J Clin Pathol"},{"key":"5652_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00428-008-0689-3","volume":"453","author":"S Dacic","year":"2008","unstructured":"Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, et al. Prognostic significance of p16\/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch. 2008;453:627\u201335.","journal-title":"Virchows Arch"},{"key":"5652_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/carcin\/23.7.1127","volume":"23","author":"T Hirao","year":"2002","unstructured":"Hirao T, Bueno R, Chen C, Gordon G, Heilig E, Kelsey K. Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis. 2002;23:1127\u201330.","journal-title":"Carcinogenesis."},{"key":"5652_CR16","first-page":"2108","volume":"9","author":"PB Illei","year":"2003","unstructured":"Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003;9:2108\u201313.","journal-title":"Clin Cancer Res"},{"key":"5652_CR17","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","volume":"66","author":"F Lopez-Rios","year":"2006","unstructured":"Lopez-Rios F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of Aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006;66:2970\u20139.","journal-title":"Cancer Res"},{"key":"5652_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","volume":"135","author":"SE Monaco","year":"2011","unstructured":"Monaco SE, Shuai Y, Bansal M, Krasinskas AM, Dacic S. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol. 2011;135:619\u201327.","journal-title":"Am J Clin Pathol"},{"key":"5652_CR19","first-page":"425","volume":"18","author":"T Papp","year":"2001","unstructured":"Papp T, Schipper H, Pemsel H, Bastrop R, M\u00fcller K, Wiethege T, Weiss D, Dopp E, Schiffmann D, Rahman Q. Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Int J Oncol. 2001;18:425\u201333.","journal-title":"Int J Oncol"},{"key":"5652_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1440-1827.2010.02534.x","volume":"60","author":"M Takeda","year":"2010","unstructured":"Takeda M, Kasai T, Enomoto Y, Takano M, Morita K, Kadota E, Nonomura A. 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis. Pathol Int. 2010;60:395\u20139.","journal-title":"Pathol Int"},{"key":"5652_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/modpathol.2008.45","volume":"21","author":"S Chiosea","year":"2008","unstructured":"Chiosea S, Krasinskas A, Cagle PT, Mitchell KA, Zander DS, Dacic S. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas. Mod Pathol. 2008;21:742\u20137.","journal-title":"Mod Pathol"},{"key":"5652_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lungcan.2009.05.004","volume":"68","author":"C Flores-Staino","year":"2010","unstructured":"Flores-Staino C, Darai-Ramqvist E, Dobra K, Hjerpe A. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions. Lung Cancer. 2010;68:39\u201343.","journal-title":"Lung Cancer"},{"key":"5652_CR23","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/cncr.23413","volume":"114","author":"FB Onofre","year":"2008","unstructured":"Onofre FB, Onofre AS, Pomjanski N, Buckstegge B, Grote HJ, Bocking A. 9p21 deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Cancer. 2008;114:204\u201315.","journal-title":"Cancer."},{"key":"5652_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1378\/chest.09-1951","volume":"138","author":"S Savic","year":"2010","unstructured":"Savic S, Franco N, Grilli B, Barascud Ade V, Herzog M, Bode B, Loosli H, Spieler P, Schonegg R, Zlobec I, et al. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest. 2010;138:137\u201344.","journal-title":"Chest."},{"issue":"12","key":"5652_CR25","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","volume":"142","author":"KB Berg","year":"2018","unstructured":"Berg KB, Dacic S, Miller C, Cheung S, Churg A. Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas. Arch Pathol Lab Med. 2018;142(12):1549\u201353.","journal-title":"Arch Pathol Lab Med"},{"key":"5652_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2016.1145850","volume":"17","author":"AC Borczuk","year":"2016","unstructured":"Borczuk AC, Pei J, Taub RN, Levy B, Nahum O, Chen J, Chen K, Testa JR. Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration. Cancer Biol Ther. 2016;17:328\u201335.","journal-title":"Cancer Biol Ther"},{"key":"5652_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","volume":"69","author":"B Christensen","year":"2009","unstructured":"Christensen B, Houseman E, Godleski J, Marsit C, Longacker J, Roelofs C, Karagas M, Wrensch M, Yeh R, Nelson H, et al. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res. 2009;69:227\u201334.","journal-title":"Cancer Res"},{"key":"5652_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.ajpath.2010.10.039","volume":"178","author":"D Jean","year":"2011","unstructured":"Jean D, Thomas E, Manie E, Renier A, de Reynies A, Lecomte C, Andujar P, Fleury-Feith J, Galateau-Salle F, Giovannini M, et al. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. Am J Pathol. 2011;178:881\u201394.","journal-title":"Am J Pathol"},{"key":"5652_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molonc.2012.07.006","volume":"7","author":"P Nymark","year":"2013","unstructured":"Nymark P, Aavikko M, M\u00e4kil\u00e4 J, Ruosaari S, Hienonen-Kempas T, Wikman H, Salmenkivi K, Pirinen R, Karjalainen A, Vanhala E, et al. Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients. Mol Oncol. 2013;7:29\u201340.","journal-title":"Mol Oncol"},{"key":"5652_CR30","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1158\/0008-5472.CAN-06-0199","volume":"16","author":"P Nymark","year":"2006","unstructured":"Nymark P, Wikman H, Ruosaari S, Hollm\u00e9n J, Vanhala E, Karjalainen A, Anttila S, Knuutila S. Identification of specific gene copy number changes in asbestos-related lung cancer. Cancer Res. 2006;16:5737\u201343.","journal-title":"Cancer Res"},{"key":"5652_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/jcp.2005.029652","volume":"59","author":"KJ Butnor","year":"2006","unstructured":"Butnor KJ. My approach to the diagnosis of mesothelial lesions. J Clin Pathol. 2006;59:564\u201374.","journal-title":"J Clin Pathol"},{"key":"5652_CR32","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.5858\/2010-0086-RAR.1","volume":"134","author":"WD Travis","year":"2010","unstructured":"Travis WD. Sarcomatoid neoplasms of the lung and pleura. Arch Pathol Lab Med. 2010;134:1645\u201358.","journal-title":"Arch Pathol Lab Med."},{"key":"5652_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ajim.4700210205","volume":"21","author":"T Tuomi","year":"1992","unstructured":"Tuomi T. Fibrous minerals in the lungs of mesothelioma patients: comparison between data on SEM, TEM, and personal interview information. Am J Ind Med. 1992;21:155\u201362.","journal-title":"Am J Ind Med"},{"key":"5652_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5271\/sjweh.226","volume":"23","author":"A Tossavainen","year":"1997","unstructured":"Tossavainen A. A reporter. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997;23:311\u20136.","journal-title":"Scand J Work Environ Health"},{"key":"5652_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ygyno.2003.08.034","volume":"91","author":"H Lassus","year":"2003","unstructured":"Lassus H, Leminen A, Lundin J, Lehtovirta P, B\u00fctzow R. Distinct subtypes of serous ovarian carcinoma identified by p53 determination. Gynecol Oncol. 2003;91:504\u201312.","journal-title":"Gynecol Oncol"},{"key":"5652_CR36","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/sj.bjc.6605012","volume":"100","author":"E Kettunen","year":"2009","unstructured":"Kettunen E, Aavikko M, Nymark P, Ruosaari S, Wikman H, Vanhala E, Salmenkivi K, Pirinen R, Karjalainen A, Kuosma E, et al. DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. Br J Cancer. 2009;100:1336\u201342.","journal-title":"Br J Cancer"},{"key":"5652_CR37","doi-asserted-by":"publisher","first-page":"e18828","DOI":"10.1371\/journal.pone.0018828","volume":"6","author":"DA Altomare","year":"2011","unstructured":"Altomare DA, Menges CW, Xu J, Pei J, Zhang L, Tadevosyan A, Neumann-Domer E, Liu Z, Carbone M, Chudoba I, et al. Losses of both products of the Cdkn2a\/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS One. 2011;6:e18828.","journal-title":"PLoS One"},{"key":"5652_CR38","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1016\/j.cub.2017.09.007","volume":"27","author":"T Chernova","year":"2017","unstructured":"Chernova T, Murphy FA, Galavotti S, Sun XM, Powley IR, Grosso S, Schinwald A, Zacarias-Cabeza J, Dudek KM, Dinsdale D, et al. Long-fiber carbon nanotubes replicate asbestos-induced mesothelioma with disruption of the tumor suppressor gene Cdkn2a (Ink4a\/Arf). Curr Biol. 2017;27:3302\u20133314 e3306.","journal-title":"Curr Biol"},{"key":"5652_CR39","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.18632\/oncotarget.13594","volume":"8","author":"G Yoon","year":"2017","unstructured":"Yoon G, Koh CW, Yoon N, Kim JY, Kim HS. Stromal p16 expression is significantly increased in endometrial carcinoma. Oncotarget. 2017;8:4826\u201336.","journal-title":"Oncotarget."},{"key":"5652_CR40","doi-asserted-by":"crossref","first-page":"64665","DOI":"10.18632\/oncotarget.11660","volume":"7","author":"N Yoon","year":"2016","unstructured":"Yoon N, Yoon G, Park CK, Kim HS. Stromal p16 expression is significantly increased in malignant ovarian neoplasms. Oncotarget. 2016;7:64665\u201373.","journal-title":"Oncotarget."},{"key":"5652_CR41","doi-asserted-by":"publisher","first-page":"36396","DOI":"10.1074\/jbc.M111.257071","volume":"286","author":"JP Coppe","year":"2011","unstructured":"Coppe JP, Rodier F, Patil CK, Freund A, Desprez PY, Campisi J. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J Biol Chem. 2011;286:36396\u2013403.","journal-title":"J Biol Chem"},{"key":"5652_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1289\/ehp.11151","volume":"116","author":"BC Christensen","year":"2008","unstructured":"Christensen BC, Godleski JJ, Roelofs CR, Longacker JL, Bueno R, Sugarbaker DJ, Marsit CJ, Nelson HH, Kelsey KT. Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect. 2008;116:723\u20136.","journal-title":"Environ Health Perspect"},{"key":"5652_CR43","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","volume":"2","author":"RM Flores","year":"2007","unstructured":"Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol. 2007;2:957\u201365.","journal-title":"J Thorac Oncol"},{"key":"5652_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.athoracsur.2015.04.087","volume":"100","author":"G Leuzzi","year":"2015","unstructured":"Leuzzi G, Rea F, Spaggiari L, Marulli G, Sperduti I, Alessandrini G, Casiraghi M, Bovolato P, Pariscenti G, Alloisio M, et al. Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: a multicenter analysis. Ann Thorac Surg. 2015;100:890\u20137.","journal-title":"Ann Thorac Surg"},{"key":"5652_CR45","first-page":"A455","volume":"75","author":"C Madrigal","year":"2018","unstructured":"Madrigal C, Aguilar G, Ju\u00e1rez CA, Trujillo O, Jim\u00e9nez C, Trejo LA, Fierro D, Calder\u00f3n ES. 1382 survival analysis of malignant pleural mesothelioma in mexican workers. OEMED. 2018;75:A455.","journal-title":"OEMED."},{"key":"5652_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cancergen.2013.04.006","volume":"206","author":"G Klorin","year":"2013","unstructured":"Klorin G, Rozenblum E, Glebov O, Walker RL, Park Y, Meltzer PS, Kirsch IR, Kaye FJ, Roschke AV. Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines. Cancer Genet. 2013;206:191\u2013205.","journal-title":"Cancer Genet"},{"key":"5652_CR47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","volume":"104","author":"T Hida","year":"2017","unstructured":"Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, et al. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer. 2017;104:98\u2013105.","journal-title":"Lung Cancer"},{"key":"5652_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ijc.23949","volume":"124","author":"SV Ivanov","year":"2009","unstructured":"Ivanov SV, Miller J, Lucito R, Tang C, Ivanova AV, Pei J, Carbone M, Cruz C, Beck A, Webb C, et al. Genomic events associated with progression of pleural malignant mesothelioma. Int J Cancer. 2009;124:589\u201399.","journal-title":"Int J Cancer"},{"key":"5652_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000109618","volume":"119","author":"P Lindholm","year":"2007","unstructured":"Lindholm P, Salmenkivi K, Vauhkonen H, Nicholson A, Anttila S, Kinnula V, Knuutila S. Gene copy number analysis in malignant pleural mesothelioma using oligonucleotide array CGH. Cytogen Genome Res. 2007;119:46\u201352.","journal-title":"Cytogen Genome Res"},{"key":"5652_CR50","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/gcc.20475","volume":"46","author":"C Zanazzi","year":"2007","unstructured":"Zanazzi C, Hersmus R, Veltman I, Gillis A, van Drunen E, Beverloo H, Hegmans J, Verweij M, Lambrecht B, Oosterhuis J, et al. Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines. Genes Chrom Cancer. 2007;46:895\u2013908.","journal-title":"Genes Chrom Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5652-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5652-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T23:23:20Z","timestamp":1694906600000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5652-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5652"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5652-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Coordinating Ethical Review Board, Helsinki and Uusimaa Hospital District and the Ethical Review Board for Research in Occupational Health and Safety, Helsinki, Finland, approved the collection of specimens, the study protocol, and the use of the specimens and asbestos fiber analysis results, obtained originally for diagnostic purposes. The patients are deceased, consent from them was not required (Dnro 39\/13\/03\/00\/09; Dnro 105\/13\/03\/00\/2013, Dnro TTL\/2\/2016; Dnro THL\/1055\/5.05.01\/2013; Dnro 5929\/06.01.03.01\/2013).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"507"}}